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SUMMARY 
 
The establishment of transgenesis in axolotls is crucial for studying development and 
regeneration, as it would allow for long-term cell fate tracing as well as gene 
expression analysis, therefore we were interested in both obtaining animals expressing 
the transgene with little mosaicism in F0 generation and transgenesis. We 
demonstrate here that plasmid injection into the one cell stage axolotl embryo 
generates transgenic animals that display germline transmission of the transgene. 
However, the efficiency of simple plasmid injection is very low, expression of the 
transgene is mosaic and seems to be promoter dependant. 
We have tested several methods of transgenesis developed in other systems. First we 
used Adeno-associated Viral Inverted Terminal Repeats inserted into the injected 
construct to enhance the expression level of the transgene and reduce mosaicism (Fu 
et al., 1998). However, in the axolotl system we do not observe the enhancement of 
expression. Moreover, the expression appeared to be transient and disappeared after 
two months. 
Further, we tested the effect of inclusion of SceI meganuclease in the injections, 
successful transgenesis method in the medaka system (Thermes et al., 2002). It 
resulted in a higher percentage of F0 animals displaying strong, stable expression 
throughout the body. This represents the first demonstration in the axolotl of germline 
transmission of a transgene. Using this technique we have generated a germline 
transgenic animal expressing GFP ubiquitously in all tissues examined.  
We have used this animal to study cell fate in the dorsal fin during development.  We 
have discovered a contribution of somite cells to dorsal fin mesenchyme in the 
axolotl, which was previously assumed to derive solely from neural crest.  
We have also studied the role of blood during tail regeneration by transplanting the 
ventral blood-forming region from GFP+ embryos into unlabeled hosts. During tail 
regeneration, we do not observe GFP+ cells contributing to muscle or nerve, 
suggesting that during tail regeneration blood stem cells do not undergo significant 
plasticity.  
We are interested in characterization of a pluripotency of blastema cells. Previously, it 
has been shown that neural progenitor cells from the spinal cord can transdifferentiate 
to a muscle and other tissue types in the regenerating tail (Echeverri and Tanaka, 
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2002a). To test if blastema cells have the potency of differentiating into a neural 
tissue, we transplanted GFP+ 4 day blastema into an injured spinal cord. Our result 
shows that blastema cells don’t seem to contribute to the regenerating spinal cord.  
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1  GENERAL INTRODUCTION  
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1.1 Introduction – on the importance of transgenesis 
 
The production of transgenic animals is a powerful tool used successfully in many 
animal systems to study early embryogenesis, organogenesis and adult tissues. It 
would be a particularly important technique for studying regeneration, as it would 
allow for long-term cell fate tracing, as well as gene expression analysis, two 
important aspects of understanding regeneration on a mechanistic level. Vertebrate 
regeneration is studied in several different model organisms, including caudata 
(salamanders) such as Ambystoma mexicanum (axolotl), anurans such as Xenopus 
laevis, and teleosts such as Danio rerio (zebrafish) and Oryzias latipes (medaka).  
Each of these systems has distinct features for studying regeneration and these 
distinctions make it crucial to have transgenic and genomic resources available in 
each of the organisms. For example, Xenopus is able to regenerate its limbs and tails 
as a tadpole but then loses this capacity upon metamorphosis while salamanders retain 
the ability to regenerate a wide variety of tissues and structures including muscle, 
cartilage, skin, spinal cord, lens and jaw throughout their lifespan (Goss, 1969).  
A number of molecular and cellular aspects of regeneration are also distinct. In 
particular, wider plasticity of cell differentiation is observed during regeneration in 
caudata compared to Xenopus. Implantation and lineage tracing experiments have 
shown that in caudates, dedifferentiation of multinucleated muscle fibers into 
proliferative mononucleate cells contributes a significant number of cells to the 
blastema (Echeverri et al., 2001; Kumar et al., 2000; Lo et al., 1993). Furthermore in 
vivo tracing of spinal cord cells revealed that neural progenitors have the potential to 
switch fate and form muscle and cartilage during tail regeneration.(Echeverri and 
Tanaka, 2002a). So far, it has been accepted that differentiated state of the cells is 
rather fixed and an unchanging attribute. In this work spontaneous metaplasia in vivo 
was observed, where one type of a differentiated cell undergoes changes to form 
another differentiated cell. Such metaplasia was not observed in Xenopus cell tracking 
experiments where each tissue layer exclusively regenerated itself (Gargioli and 
Slack, 2004).  
While teleosts are able to regenerate their fins and portions of the heart, complete 
regeneration of the spinal cord, as observed in axolotls, is not possible in most teleost 
species (Kawakami et al., 2004). On a cellular level the plasticity of cell 
differentiation during teleost regeneration has not yet been widely established. 
9 
 
Work in Xenopus laevis provides an excellent example of how transgenesis can be 
used for studying regeneration. The Cre-loxP system was used to trace muscle cell 
fate during tail regeneration where it was shown that muscle fibers do not 
dedifferentiate (Gargioli and Slack, 2004; Ryffel et al., 2003). Gargioli and Slack also 
grafted embryonic tissue from GFP+ Xenopus embryos into unlabelled hosts to follow 
the fate of other tissue types and found no transdifferentiation of spinal cord and 
notochord cells during tail regeneration. To address the molecular pathways involved 
in initiating regeneration Beck and colleagues (Beck et al., 2003; Beck et al., 2001) 
created transgenic animals where key extracellular and intracellular signaling 
molecules were under the control of the Xenopus HSP70 promoter, allowing 
induction of gene expression at the time of tail amputation. This work implicated a 
role for the Notch and BMP pathways in induction of tail regeneration. These 
Xenopus studies illustrate the value of transgenic approaches for regeneration 
research. As the cellular and molecular differences between tail regeneration in 
anurans and caudata becomes more evident, the significance of studying regeneration 
in both taxa is becoming increasingly clear. 
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1.2 Overview of selected methods of gene delivery.  
 
The ability to selectively alter gene expression creates enormous possibilities in 
regeneration studies. Finding what pathway is a key player in inducing and guiding 
regeneration is an ultimate goal in regeneration research. It is, therefore, of particular 
importance to develop transgenic approaches in caudata. 
For this purpose it is necessary to establish a nomenclature of transgenesis. Germline 
integration is an introduction of exogenous DNA into the host genome and its stable 
integration the host genome, transmitted to the second generation. Transgenesis is an 
introduction of exogenous genes into the host organism, its stable integration in the 
genome and transmission to the next generation (germline integration) and proper 
expression of this transgene in the host organism. (Grabher et al., 2004). For our 
studies of tracking cell fate in the tail regeneration we are interested in obtaining the 
level of transgenesis with properly expressed transgene in the second generation. 
The axolotl is an animal easily bred under laboratory conditions with a generation 
time of approximately one year. An advantage of using axolotls is the availability of 
skin pigment mutants such as the white mutant where pigment cells are inhibited from 
migrating out laterally under the epidermis from their neural crest origin on top of the 
neural tube (Epperlein and Lofberg, 1990). These mutants facilitate visualization of 
lineage tracers such as GFP in regeneration studies (Echeverri and Tanaka, 2002b; 
Echeverri and Tanaka, 2003). Our goal was to establish an efficient transgenesis 
method for the axolotl that would allow first, production of a large number of 
transgenic animals in the F0 generation and second, germline transmission. 
There are several methods of introducing the transgene into the genome available in 
various vertebrate systems. The most efficient so far was modified sperm nuclei 
transplantation (REMI) into the oocyte in the Xenopus system (Kroll and Amaya, 
1996). This method of transgenesis results in stable, nonmosaic expression of cloned 
genes in the embryos. It is possible in Xenopus to produce a large number of 
transgenic, normally developing embryos that express transgenes at high frequencies 
– most importantly there is no need to wait for a germline transmission in F1 to obtain 
transgenics.  
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In systems like axolotl, where generation time is one year long possibility of applying 
this method and obtaining such a tool in F0 generation would be a mile stone. Since 
1996, there were attempts to simplify this complicated and technically demanding 
method (Sparrow, 2000). Ueda and colleagues (Ueda et al., 2005) successfully 
applied a modification of the Xenopus transgenic technique involving in vitro 
fertilization coupled to sperm injection to produce transgenic newt, Cynops 
pyrrogaster. Transgenic animals were generated at a frequency of approximately 2% 
and displayed uniform transgene expression throughout the body. Unfortunately, a 
disadvantage of the Cynops system is the complex life cycle and long time to sexual 
maturity, making propagation of transgenic lines complicated. Furthermore, in the 
Ueda protocol a large number of females were required to produce enough 
unfertilized eggs for a single experiment, making the possibility of producing multiple 
transgenic lines difficult. Another transgenic approach that also has been described 
for the newt (Makita et al., 1995) found that injection of fertilized Cynops eggs with a 
linearized eukaryotic expression vector containing the lacZ gene resulted in mosaic 
reporter gene expression in tailbud stage embryos. The inclusion of newt satellite 2 
sequences in the plasmid augmented the extent of expression 10-fold, with a 
widespread distribution of gene expression in hatching larvae. Germline transmission 
was not assessed in these experiments. 
In contrast to previous methods, which are quite complex, there were several simpler 
protocols of producing transgenic animals, and three of them were considered for 
application in the axolotl system.  
The plasmid injection into the one cell stage embryo is the simplest method used in 
zebrafish and Xenopus (Cleaver and Krieg, 1999; Stuart et al., 1988). It is easy and 
requires only cloning of the desired construct. However, a disadvantage of this 
method is a very low efficiency of transfection, germline transmission and 
transgenesis. In most cases the transgene remains episomal and its expression is 
mosaic, transient and weakens in time - probably due to inefficient segregation of the 
transgene during development. Moreover, it is very difficult to obtain tissue 
specificity of gene expression. 
There are two other methods which use plasmid injection in combination with factors 
enhancing integration of the transgene into the host genome and increasing possibility 
of transgenesis.  One is the application of the Adeno-associated Viral Inverted 
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Terminal Repeats (Fu et al., 1998). The Adeno- associated virus is a non-autonomous 
parvovirus requiring co-infection with another virus for productive infection and is 
completely nonpathogenic (Gaiano and Hopkins, 1996). It contains the terminal 
repeat sequences of 145 nucleotides, which form a palindromic hairpin structure that 
is required for DNA replication, integration and eventual excision of proviral 
sequences. To use the ability of integrating into the host genome of the adenovirus, it 
is necessary to build a vector where the desired expression cassette is flanked by ITR 
hairpins. As reported for Xenopus, inclusion of AAV-ITRs in DNA plasmids 
significantly increases transgene expression from a ubiquitous promoter, reduces 
ectopic expession and significantly enhances tissue specific expression (Fu et al., 
1998). This method gives results resembling the efficiency and fidelity of the sperm 
nuclear transplantation technique (Kroll and Amaya, 1996) and is simpler, however 
the transgenesis could be obtained only in F1 generation.  
A second method very successfully tested in the zebrafish system is the use of ISceI 
meganuclease enzyme (Thermes et al., 2002). ISceI meganuclease is a site specific 
endonuclease, encoded in the intronic sequence, originally discovered in S. cerevisiae 
(Belfort and Roberts, 1997). The enzyme is able to recognize and cleave an intronless 
allele and introduce the DNA fragment into the cleavage site (Colleaux et al., 1988; 
Jacquier and Dujon, 1985). The recognition sequence of the ISceI enzyme is 18 base 
pairs long with a very high specificity of recognition. The site is expected to be found 
only once in 7x1010 bp of random sequence and until now it hasn’t been found in any 
vertebrate genome. Therefore it is very unlikely that fractionation of the host genome 
will occur as it happens with the REMI technique (Kroll and Amaya, 1996). Co-
injection of the ISceI enzyme together with the plasmid containing its recognition 
sites resulted in enhanced promoter dependant expression of the transgene in F0 
generation and a significant increase in the number of expressing embryos and also in 
the number of cells expressing the transgene per embryo. Moreover, animals showed 
reduction of mosaicism and the frequency of transgenesis increased at least two fold 
compared to control injections (Thermes et al., 2002).  
After analyzing the available methods, we decided to establish a microinjection 
protocol using a plasmid with an universal promoter driving GFP, and further test 
both methods transgenesis enhancement – AAVITRs and ISceI meganuclease 
enzyme. 
13 
 
1.3 Transgenic GFP axolotl in development and regeneration 
studies 
 
The availability of a GFP transgenic animal is a valuable tool for cell tracking 
experiments, since it provides an indelible marking system with high spatial 
resolution that is visible in live animals. These animals provide a transplantation 
system comparable to the valuable quail-chick chimeras, which have been crucial for 
studying cell fate during avian embryogenesis and organogenesis (N.M. LeDouarin, 
1999). The axolotl is a particularly good system for tracking cell fate by transplanting 
tissues from a GFP+ animal into unlabeled hosts due to its unrivaled accessibility for 
tissue engraftment at any stage of its lifecycle. The transplantation of GFP+ cells 
circumvents the problems of other labeling techniques such as DiI, where the 
possibility of the dye spreading to unwanted cells always exists, or mRNA/dextran 
injection and electroporation which are relatively transient markers that are diluted 
out upon cell division.  
Here we use a GFP transgenic axolotl in embryonic tissue grafting to study three 
essential problems in development and regeneration. By transplantation of neural 
folds and somites, we demonstrate that the dorsal fin mesenchyme, which was 
originally assumed to derive entirely from neural crest (see (Tucker and Slack, 2004), 
has a dual origin, deriving from both from neural crest and somites.  
Second, we examine the issue of hematopoietic cell plasticity and its contribution to 
regeneration.  Recent reports of hematopoietic cells being able to contribute to other 
tissue lineages such as muscle or brain in the mouse have raised controversy 
(Brazelton et al., 2000; Ferrari et al., 1998; Ferrari and Mavilio, 2002; Mezey et al., 
2000). The frequency of such events, as well as their potential relevance to tissue 
regeneration are still open to question.  We wanted to test whether blood cells display 
widespread plasticity during axolotl tail regeneration—namely whether blood cells 
contribute significantly to muscle and the central nervous system. Here we do not 
observe blood cells contributing to muscle or the central nervous system during tail 
regeneration, indicating that hematopoetic cell plasticity is not an ubiquitous 
mechanism used during regeneration.  
A spinal cord during axolotl tail regeneration grows as a separate entity, however it 
has been shown that its cells can form other types of cells in the regenerating tail 
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(Echeverri and Tanaka, 2002a). We attempt to reveal whether blastema cells have the 
potential to contribute to the regenerating spinal cord. We transplant GFP+ blastema 
into the injured spinal cord. We observe the contribution of blastema cells to a 
cartilage and muscle, however in each case blastema cells were pushed away from the 
spinal cord region and did not contribute to this structure.  
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2 RESULTS 
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2.1 Introduction 
 
The axolotl system is a great model for studying regeneration. The ability of the 
animal to regenerate its lost body structures is maintained throughout the life. The 
regeneration of the tail raises numerous questions about how it is possible to 
reconstitute such a complicated structure, where not only the morphology but also its 
full function is recovered. For example, does the process of regeneration use the same 
pathways as development? What is the origin of the blastema? Is the blastema a pool 
of stem cells normally residing in the tissue that are activated upon injury or do these 
stem cells come form dedifferentaiation? Are blastema cells pluripotent or do they 
have a restricted fate? 
There have been several reports on the origin of blastema cells (Echeverri et al., 2001; 
Echeverri and Tanaka, 2002b; Muneoka et al., 1986). However, in all of them authors 
used dyes, transient expression of markers or a triploid/diploid cell marker. The use of 
dye (e.g. rhodamin dextran) to label cells allows only short-term fate tracking because 
cells lose the marker upon proliferation due to dilution of the dye. It is also not 
possible to exclude that dye can pass to another cell – a problem difficult to overcome 
while tracking the fate of a single cell. 
The transient expression of markers in the axolotl is very ineffective in long-term cell 
tracking because the expression is lost upon dedifferentiation. We were not able to 
determine so far if this is due to the loss of the plasmid or silencing. In tracking cell 
fate during regeneration, labeling a single cell is crucial. However, delivering the 
plasmid to a single cell by electroporation always leaves the possibility of inadvertent 
labeling adjacent cells. Furthermore, even when cell labeling is marked, the label is 
not stable. For example, the fate of muscle fibers in the regenerating tail is still an 
open question. The possibility of satellite cells populating the blastema and 
reconstituting muscle fibers of the tail not cells originating form the dedifferentiation 
of the muscle fiber still remains to be elucidated.  
The triploid/diploid marker system has another disadvantage. The visualization of 
nucleoli requires fixing, sectioning and staining with bismuth (cite chicken and quail 
paper) therefore this method also limits in vivo long-term observations of blastema 
and regeneration. 
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The axolotl is a very suitable system for studying embryo development due to its very 
large embryo which is easily accessible for observations. The 2mm diameter of the 
embryo allows fair fidelity and reproducibility of transplantations. Previously 
Spemann and Mangold used salamanders to discover the organizing center of 
embryonic induction in 1924 (Spemann, 1924). However, technical difficulties 
pushed scientists toward easier system – Xenopus, where seasonal variability and 
accessibility of embryos is being overcome by hormone injections and in vitro 
fertilization. Availability of transgenic tools also played an important role in using the 
Xenopus system to study early development instead of axolotl.  
The most effective way to overcome these problems and answer the above questions 
is to create transgenic animals which would allow the stable labeling of the cells or 
tissues. 
Due to the complications of applying the Xenopus protocol to caudate eggs, described 
by Ueda by colleagues (Ueda et al., 2005), we chose to test transgenesis protocols that 
are widely used in teleosts.  Transgenesis in teleosts is normally achieved via direct 
injection of plasmid DNA into the fertilized egg. This results in F0 animals 
expressing the transgene in a mosaic fashion, a proportion of which display germline 
transmission of the transgene (Culp et al., 1991; Stuart et al., 1988; Stuart et al., 
1990). It was recently reported that coinjection of ISceI meganuclease with plasmids 
bearing its recognition sites enhances expression, decreases mosaicism in the F0 
generation, and increases the germline transmission rate (Thermes et al., 2002).  Here 
we describe plasmid injection into the one cell stage axolotl embryo as a method of 
generating transgenic animals and the evaluation of ISceI meganuclease's ability to 
enhance expression. Using this technique we report for the first time in the axolotl 
germline transmission of a transgene in a Mendelian ratio. 
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2.2 Estimation of the quality of embryos. 
 
There are a few important issues to solve for in order for axolotl to become easily 
accessible and suitable for transgenesis. In the system of Xenopus there are well-
established protocols of collecting embryos. Hormone injection is used to allow 
constant rather than seasonal production of large amount of eggs. Moreover, a very 
efficient protocol for embryo dejelling exists. Similar techniques have yet to be 
established for the axolotl.  
The seasonal variability of embryos can be diminished to a great extent by breading 
animals in stable conditions all year long, which we can provide in our colony. So far 
we were not able to work out an efficient protocol for the collection of oocytes after 
hormone induction. From our experience so far, hormone injection in order to induce 
an animal to lay oocytes causes an unexplained imbalance in the animal’s biology 
resulting in infertility. Because of this we were unable to work out the in vitro 
fertilization protocol. 
Axolotl spawning results in 400-600 embryos on average. Under normal conditions, 
embryos are laid during the whole day and they are covered by protective eggshell 
and jelly coat. When the embryos are collected the spectrum of developmental stages 
varies from stage 1 to at least 6. The time necessary to complete the first cell division 
in axolotl is 6 hours. This gives an opportunity to collect a relatively large number of 
embryos in the one cell stage. In the Xenopus system there is an efficient protocol for 
dejelling embryos. It takes only 2 minutes to remove a Xenopus embryo coat by 
washing in 2% cysteine solution. Transgenesis by plasmid injection requires delivery 
of the transgene to the embryo at the earliest possible stage, before the first cell 
cleavage has taken place. This increases the probability of transgene integration into 
one set of the genome, and Mendelian transfer of the gene upon mating.  
Here the average quality of embryos collected in our colony and the possibilities of 
efficient chemical dejelling in comparison to manual jelly coat removal is being 
investigated. The average quality of embryos in our colony was established by 
comparison of survival rates of 4 spawnings (Figure 1). Embryos were collected, 
counted and left to develop at room temperature; water was changed every second 
day, and dead embryos were removed. After two weeks embryos were scored again. 3 
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out of 4 batches showed survival rate of 65% of average, whereas a fourth batch 
showed only a 28% survival rate. This suggests that occasionally the ability of 
embryos to survive is low from the start and when used in an experiment may not 
deliver a conclusive or representative result. This observation was further confirmed 
during later experiments, where animals occasionally were dying for no apparent 
reason. On average, approximately 60% of embryos develop normally and survive 
until at least until stage 43, when the embryo naturally hatches out of the coat.  
Knowing the average survival rate of embryos, it became necessary to test whether 
manual dejelling is damaging to the embryos. Several batches of embryos were 
dejellied and left to develop. In Figure 2 the comparison of two manually dejellied 
embryo batches. Batch No.1 represents a very good quality pool of embryos. In this 
situation manual dejelling has no effect on embryos’ survival (and development). 
Therefore, careful manual procedure in sterile conditions is sufficient to obtain a large 
amount of embryos of the desired stage without mechanical damage. However, batch 
No.2 represents pool of bad quality embryos, which can be seen by the fact that even 
non-dejelied embryos survive poorly. In this case, mechanical removal of the coat is 
another factor contributing to the dramatic decrease of survival, and animals which do 
develop show severe malformations.  
The 60% of surviving embryos and efficiency of manual dejelling was used as the 
base for establishing whether it is feasible to develop an efficient chemical dejelling 
protocol in axolotl, which would be comparable to the Xenopus protocol. The 
requirement was shortening the time of the dejelling procedure and maximum 
viability of embryos after treatment – which ideally is a 55-60% survival rate – close 
to the natural survival rate. 
We chose several chemicals to test:  2% cysteine – very successfully used in Xenopus, 
collagenase (concentration range: 0.5mg/ml – 2mg/ml), dispase, collagenase/dispase 
mix, trypsin and 2.5% thioglycolic acid, pH=9, and various other combinations of 
these chemicals. Using 2.5% Thioglycolic acid, pH=9.0, with the time-range tested – 
25-50 min, on average 70% embryos loose their coat, however, less than 10% survive 
longer than one week. In the case of collagenase, we used a concentration range of 
0.5mg/ml – 2mg/ml within time points of 20 and 47 min. The coat removal was 60 
and 86%, respectively, and survival of the embryos was less than 20% after 1 week. 
In the case of collagenase – dispase mix, in the concentrations of 2mg/ml/0.5mg/ml 
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for 8 min the result was 57% coat removal and 2% survival after one week. Using the 
lower concentration of collagenase-dispase mix (0.5mg/ml;0.1mg/ml) for 47 min 
resulted in the removal of the eggshell in 83% of embryos with 43 % of them 
surviving one week. Dispase and trypsin alone even in low concentrations was very 
toxic to the embryos. Several combinations of proteases and 2.5%TA, pH=9, gave no 
satisfactory result in terms of timing and embryo survival. In the case of 2% cysteine 
treatment after 30 minutes, we observe only jelly coat removal and the eggshell 
remains intact. 
The low concentration of collagenase-dispase mix (0.5mg/ml:0.1mg/ml) was the 
closest result to the relatively good survival observed normally. However, the 
duration of dejelling in comparison to Xenopus, where it takes 2 minutes to remove 
the coat, is unacceptable. No result lower than 10 minutes was obtained that gave coat 
removal in more than 90% of embryos and a survival rate higher than 60 % was 
reached. Therefore, it became necessary to master manual dejelling and this procedure 
was used to remove the coat from embryos in further experiments. 
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Figure 1. Four batches of embryos were collected, scored and allowed to develop. 
Three of them have similar rates of survival after 1 month. Occasionally, a very 
poor quality batch occurs. On average, the survival rate of embryos is 60%. 
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Figure 2. Batches of embryos can have a very different quality. Here the effect of 
mechanical damage on healthy and unhealthy embryos during manual dejelling 
is shown. If spawning results in healthy embryos, careful manual dejelling has no 
effect on survival and development of embryos (batch1). However, the 
mechanical removal of the jelly coat from embryos more delicate, or less healthy, 
caused dramatic decrease in survival and severe developmental malformations. 
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2.3 Plasmid injection results in mosaic transgene expression with 
the duration of expression being promoter dependent 
 
To assess the efficacy of plasmid injection for generating stable transgene expression, 
we tested plasmids harboring three different constitutive promoters driving green 
fluorescent protein: cytomegalovirus (CMVGFP), X borealis cytoskeletal actin 
(CSKAhGFP;  (Thermes et al., 2002), and cytoplasmic actin fused to the CMV 
enhancer, (CAGGsEGFP; (Niwa et al., 1991). In this experiment we injected 2ng of 
DNA/egg. All plasmids yielded mosaic expression of fluorescent protein in the 
developing embryos ranging from the labeling of an occasional cell, to animals where 
at least 50% of the body cells expressed the transgene.  
 
To evaluate and compare the extent of mosaicism and intensity of expression we 
categorized the hatchlings into four expression categories (Table 1). “Very strong” 
indicated animals that displayed almost ubiquitous expression of GFP so that under 
the stereomicroscope the intensity of fluorescence was relatively uniform and distinct 
patches of cells were not visible. The “strong” category denoted animals where 
expression was widespread and strong, but some mosaicism was evident, with clearly 
visible patches of muscle, skin, heart, blood cells, veins, neural system and notochord. 
“Moderate” denoted animals with a weaker intensity of fluorescence in greater than 
50% of the cells or animals with a higher intensity of fluorescence in slightly less than 
50% of cells. Such animals typically expressed the reporter gene mostly in body 
muscles and skin and with very few blood cells and heart labeled. The “weak” 
category represented weak expression of reporter gene and was mostly limited to 
small patches of body muscles and scattered patches of skin. From these observations 
it was clear that the intensity and extent of expression was promoter dependent (Table 
1). 
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 Categories of expression at hatchling Duration and intensity of EGFP expression in time 
Promoter Survived/ Injected (%) 
Rate 
of expression 
%(No) 
Very strong 
No/% 
survivors 
Strong 
No/% 
survivors 
Moderate 
No/% 
survivors 
Weak 
No/% 
survivors 
Embryo Hatchling 
Larvae 
(2mth) 
 
CMV 
 
113/639 
18% 
34% (38) 
    38(100) 
++ + - 
CSKA 
 
10/180 
6% 
50% (5) 
   2(40) 3(60) 
++ + + 
CAGGs 
 
6/51 
12% 
100%(6) 
 1(17) 5(83)   
+++ +++ +++ 
Table 1. Comparison of expression levels, duration of expression and survival rate of animals injected with three different promoters: 
CMV – cytomegalovirus promoter, CSKA – X. borealis cytoskeletal actin promoter, CAGGs – chicken b-actin promoter combined with 
IE CMV enhancer. 
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Significantly, the different promoters showed widely different persistence of 
expression over the course of development. The expression driven by the CMV 
promoter decreased steeply over time to the stage where all animals lost most of the 
fluorescent labeling by 2 months and only small, scattered groups of muscle or skin 
cells continued to express label (Table 1). The CSKA promoter, although a cellular 
promoter, was also mildly silenced over time. In contrast, the expression obtained 
from the CAGGs promoter was strong and most importantly this strong expression 
persisted beyond 6 months (Figure 3A and B). The one F0 male that displayed “very 
strong” GFP expression in close to all cells of the body was grown for 14 months to 
sexual maturity. Expression of GFP was stable throughout development and into 
adulthood (Figure 3A and B).  Considering the persistence of the CAGGs-driven 
expression, it is likely that the CMV-driven construct is silenced in the genome over 
time. Indeed delivery of CMV promoter driven constructs into rat muscle via 
adenovirus injection is extensively silenced soon after delivery to the cell (Brooks et 
al., 2004).  Silencing of CMV-promoter driven gene expression has also been 
described in transgenic Xenopus (Ryffel et al., 2003). In contrast the CAGGs 
promoter has been used for widespread expression in transgenic mice (for example: 
(Okabe et al., 1997), and our results confirm its effectiveness in promoting ubiquitous 
expression in transgenic animals.  
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Figure 3. Axolotl injected with CAGGsEGFP construct - founder animal of our 
first transgenic line of axolotl. CAGGs - chicken B-actin+IE CMV promoter. A. 
Expression of EGFP after 1 month. The animal is about 1.2 cm long. B. 
Expression of EGFP in the same animal after 6 months. The animal is about 13 
cm long. Expression at this level was observed until the first mating. C. F1 
animals derived from mating the GFP+ of transgenic axolotl.  Progeny are at the 
2cm long larval stage. GFP is ubiquitously expressed all over the body. 
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2.4 Testing Adeno-associated virus inverted terminal repeats (AAV-
ITRs) in the axolotl system 
 
Fu and colleagues (Fu et al., 1998) have reported a strategy for efficient and stable 
expression of transgenes driven by both ubiquitous and tissue-specific promoters by 
direct DNA injection into developing Xenopus embryos. This strategy involves 
flanking expression cassettes of interest with inverted terminal repeat sequences 
(ITRs) from adeno-associated virus. Their results show that, when injected with 
CMVnBgal-ITRs (linearized), 65% of scored embryos expressed the transgene in 
more than 50% of the progeny of injected cells. Although these results look 
promising, they report that the amount of plasmid DNA in injected embryos decreases 
steadily from stage 22 onward, and at comparable rates for both ITR-containing and 
non-ITR-containing plasmids (southern blot analyses on DNA extracted from 
embryos in different stages), so the conclusion was that integration may be occurring 
at a relatively low frequency. 
Moreover, the authors found that ITR sequences restrict ectopic expression of  -
cardiac actin promoter. Whereas 52% of scored embryos injected with linearized 
control plasmid (no ITRs) exhibited ectopic GFP mRNA expression, only 19% of 
scored embryos injected with linearized ITR-containig plasmid exhibited ectopic GFP 
expression and in the latter group ectopic expression was limited to one or very few 
cells. Considering both the resemblance of Xenopus and axolotl and the ability of 
AAV ITRs to function both in mammalian cells and in Xenopus, it is reasonable to 
think that this method may give similar efficiencies in our system within a single 
generation. 
In vivo studies on axolotl tail regeneration require the use of an easily detectable and 
traceable marker. Therefore, GFP was used instead of nβgal (see Materials and 
Methods). Initially the 0.01-1ug/ul range of plasmid concentration in the injection 
solution was tested, resulting in the best survival with the lowest concentration (Table 
2). However, the expression in surviving animals was so weak that we decided to 
further use 0.1ug/µl in 20nl drop per embryo, sacrificing the best survival for a better 
expression. 
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C 
(ug/ul) 
Nr of injected 
embryos 
Nr of survived 
embryos 
% of survived 
embryos 
0.01 40 17 43% 
0.1 40 4 10% 
pCS2 G
FP ITR 1 40 0 0 
Table 2. Titration of pCS2GFPITR plasmid in order to test embryo survival. It is 
dependant on the plasmid concentration in the injection solution. Embryos were 
scored 3 weeks after injection. 
 
Further experiments were designed to compare expression of GFP obtained from a 
plasmid containing ITRs (in circular and linear version) with the same plasmid 
without ITRs. The goal of this experiment was to confirm if it is possible using the 
Xenopus protocol to reach similar efficiencies in the axolotl system and if it is 
possible to apply this method to obtain transgenic axolotl lines. Table 3 shows the 
result of injecting a plasmid containing ITRs compared to non-ITR plasmid injection.  
 
 Nr of 
Injected 
embryos 
Nr of 
Survived 
embryos 
% of 
Survived 
embryos 
Nr of 
Survivors 
expressing 
GFP 
% of 
Survivors 
expressing 
GFP 
pCS2GFPITR 400 54 14 19 35 
pCS2GFPITR(lin) 80 14 18 8 57 
pCS2GFP 78 17 22 - - 
pCS2GFP(lin) 79 23 29 - - 
Table 3. Evaluation of AAV-ITR transgenesis method in axolotl. Animals were 
scored for survival and the presence of GFP expression after 4 weeks. (lin) – 
plasmid linearized.  
 
As we could observe, the survival of embryos does not exceed 30% with a slight 
decrease in survival when viral ITR sequences were included in the plasmid. 
Linearization of the plasmid shows a tendency for higher survival. In the case of 
plasmids without ITRs, none of the surviving animals expressed GFP at the time of 
examination (4 weeks). Only 35% of the survivors in the case of circular plasmid 
injection express GFP. A slightly higher number of animals expressing GFP is 
observed when a linear plasmid was injected. The expression was first examined 
under a fluorescent microscope after 4 weeks. The expression level was moderate and 
mosaic with a different intensity of labeled cells. Mostly muscle fibers were labeled, 
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with occasional patches of skin and blood vessels. Moreover, after 6 weeks, 
expression had gradually decreased to only a few muscle fibers labeled in most cases. 
No animal with strong, ubiquitous and stable expression of GFP was obtained with 
this method. 
There are several explanations for this result. One possibility is that no integration 
occurred; DNA remained episomal and was distributed as such to descendant cells in 
the developing embryo. However, with a very low frequency, the possibility of 
integration of the transgene in later stages of development exists, as evidenced by 
some cells remaining GFP+ for more than 5 months. Another phenomenon possibly 
explaining the decrease of GFP expression could be the silencing of integrated CMV 
promoter (Garrick et al., 1998). 
Having this result, it could not be confirmed that AAV-ITR act to promote or enhance 
integration of the transgene in the axolotl system. Animals produced using this 
method do not seem to have the potential for germline transmission and, since the 
expression decreases, they cannot be used for lineage tracing experiments. However, 
the short-term expression (during embryonic stages) was clearly higher than in the 
case of the non-ITR plasmid. Hence, it could be used for expression of transgenes for 
studying embryonic development. The tissue specific expression or non-viral 
universal promoter in combination with ITRs was not tested. 
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2.5 Coinjection of ISceI meganuclease enzyme with a plasmid 
containing its recognition sites enhances transgene expression  
 
One goal was to develop a transgenesis method where we could produce relatively 
large numbers of animals with the least mosaicism possible in the F0 generation so 
that the F0 animals might be used directly in cell tracking experiments, as is done in 
Xenopus. A second consideration was germline transmission of the transgene. To 
reduce mosaicism in the F0 generation and to increase the chance of germline 
transmission we tested a method successfully implemented in medaka involving 
coinjection of ISceI enzyme mixed with plasmid containing its recognition sites 
(Thermes et al., 2002). ISceI meganuclease is an intron-encoded homing 
endonuclease with an 18 bp long recognition sites that was isolated from S.cerevisiae 
(Jacquier and Dujon, 1985). The meganuclease enzyme induces double stranded 
break formation at its recognition sites and probably also takes part in double strand 
break repair (Rouet et al., 1994).  
To test whether the ISceI method alleviates mosaicism, we constructed a pCAGGs-
EGFP plasmid where Sce sites flanked the expression cassette and injected the 
pCAGGsEGFP(Sce) and pCAGGsEGFP plasmids with and without enzyme. In initial 
experiments we tested optimal plasmid and enzyme concentrations by a series of 
plasmid injections in the range from 2ng to 500pg per embryo. Optimal results were 
obtained with injection of 1ng of plasmid per embryo. With this amount of plasmid 
the optimal enzyme amount was established by series of injections where the enzyme 
concentration was varied from 0.01 to 4U/µl. 1U/µl (10nU/embryo) of enzyme in the 
injection mix yielded optimal results in terms of embryo survival but most of all the 
number of animals showing very strong expression of GFP was highest. Co-injection 
of pCAGGsEGFP(Sce) with the ISceI enzyme resulted in 16% of animals classified 
as “very strong” (Figure 4) in comparison to the control injections where only 2% of 
animals were in this class (Table 4).  
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Figure 4. Animals obtained from co-injections of GFP plasmid and ISceI 
meganuclease enzyme were scored according to categories A, very strong;  B, 
strong; C, moderate; D, weak. Scale bars: A, D 0.1cm, B 0.5cm, C 0.3cm.  
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 Construct Injected No 
Survived 
No/% 
Very strong 
No/% 
survivors 
Strong 
No/% 
survivors 
Moderate 
No/% 
survivors 
Weak 
No/% 
survivors 
CAGGS GFP SCE+E 281 92 (33%) 15 (16%) 9 (10%) 31 (34%) 37 (40%) 
CAGGS GFP SCE 157 74 (47%) 0 8 (11%) 23 (31%) 43 (58%) 
CAGGS GFP+E 291 68 (23%) 0 3 (4%) 9 (13%) 56 (82%) 
CAGGS GFP 223 61 (27%) 1 (2%) 3 (5%) 14 (23%) 43 (70%) 
E 155 103 (66%)     
Table 4. Embryos at one cell stage were injected with various combinations of plasmid and I-SceI enzyme. The quality of expression was 
checked after 1.5 months and animals were classified in categories of expression described in the text; E- I-SceI meganuclease enzyme. 
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2.6 Germline transmission of transgene expression  
 
To evaluate germline transmission we raised 15 F0 animals harboring the 
pCAGGsGFP plasmid to adulthood and performed matings with the white mutant. 
This experiment was performed prior to obtaining the animals from the meganuclease 
experiments described above. Therefore, the animals used for mating represented one 
male with “very strong” expression, and 14 animals with “moderate or strong” 
expression (Figure 4). In such matings 6 out of 15 animals produced at least some 
GFP+ embryos in the F1 generation, with 3 animals generating over 20% GFP+ eggs 
(Figure 4 and Table 5).   
 
Animal Sex (M/F) No of EGFP+ embryos 
No of EGFP- 
embryos 
 % embryos 
GFP+ 
1 (very strong) M 160 150 52 
2 F 159 213 43 
3 F 0 150 0 
4 F 0 183 0 
5 F 10 163 6 
6 M 3 311 1 
7 F 0 46 0 
8 M 0 62 0 
9 F 0 207 0 
10 M 0 175 0 
11 F 8 493 1 
12 F 0 59 0 
13 F 0 80 0 
14 M 40 152 21 
15 M 0 243 0 
Table 5. Germline transmission of pCAGGsEGFP 
 
Notably, the mating of the “very strong” male depicted in Figure 1 with a white 
female produced clutches where 50% of the eggs were GFP+. This result suggested 
that in this case, the transgene might be expressed from a single chromosome in all 
germ cells, resulting in Mendelian inheritance of the transgene. To confirm this ratio, 
this male was used for a second mating, resulting again in 50% eggs GFP+, 
supporting the notion of Mendelian inheritance of the transgene. In the eggs from 
these matings, GFP expression was first observed after the mid-blastula transition 
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(stage 8 of development) consistent with zygotic expression of the GFP transgene 
from the male chromosome.  
 
Figure 3C depicts the GFP+ F1 transgenic animals at the larval stage. The animals 
appear to express GFP uniformly throughout their body. To examine in more detail 
whether the GFP transgene was ubiquitously expressed in the F1 animals various 
tissues from an F1 transgenic animal were compared to those from a white animal of 
the same age. Strong, ubiquitous GFP expression was observed in dissected 
forelimbs, eyes, hearts, lungs and livers  (Figure 5). Due to our interest in tail 
regeneration and blastema formation we examined GFP expression at higher 
resolution in longitudinal cryosections of regenerating tails (Figure 6A-C).  All tissues 
including mature and regenerating spinal cord (SC), the notochord (N), epidermis (E), 
and the blastema (B) were uniformly GFP+. By examining cells at high resolution in 
the tail fin (Figure 6D-F) and the tail blastema (Figure 6G-I) we could ascertain that 
all identifiable Höchst-positive cells were also GFP+. This is particularly clear in the 
dorsal tail fin where individual cells are widely separated from each other and 
embedded in a dense extracellular matrix (Figure 6D-F).  
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Figure 5. GFP fluorescence of major organs and stuctures in GFP-transgenic 
compared to a non-transgenic animal. A and B shows comparison of eyes, C,D 
forelimbs, E,F heart,  G,H liver, I, J lung. On figures A, C, E, G, I brightfield 
and on B, D, F, H, J fluorescent images are shown. Scale bars - A, B, C, D, E, F, 
I, J - 1mm, G, H - 2mm. 
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Figure 6. High resolution images of GFP fluorescence in cryosections of a 
regenerating axolotl tail.  A regenerating tail of a transgenic fluorescent animal 
was sectioned longitudinally and stained with hematoxylin to visualize cells and 
Höchst to visualize nuclei. A, B, C An overview of the tail tissues. sc – spinal 
cord, n – notochord, b – blastema, e – epidermis. D, E, F  Higher magnification 
view of tail fin cells.  Note in hematoxylin and Höchst staning that cells are 
widely separated from each other via ECM.  All cells are GFP+ . G,H,I, High 
magnification view of tail blastema cells.  All Höchst positive cells are GFP+. 
A,D,G, hematoxylin staining.  B,E,H,  GFP fluorescence from transgenic animal, 
C,F,I overlay of GFP and Hoechst staining. Scale bars: A-C 200µm; D-F 100µm; 
G-I 50µm. 
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2.7 Somite and neural crest contribute to dorsal fin mesenchyme    
 
An animal constitutively expressing GFP is a valuable tool for analyzing the fate of 
cells during development and regeneration by grafting GFP+ cells into unlabeled 
hosts.  The axolotl is particularly amenable to such an approach as tissues at all stages 
(embryonic, larval, juvenile and adult) engraft from one animal to another extremely 
well with no evidence of rejection.  Here we have used grafting of GFP+ tissues to 
study cell fate during embryogenesis and regeneration.  We have focused on the 
formation of the dorsal fin during embryogenesis, and the contribution of blood-
derived cells to tail regeneration.   
 
We were interested in the genesis and composition of the dorsal fin mesenchyme 
since it is a structure that contributes to tail regeneration but has been little studied.  
The fin mesenchyme is composed of stellate cells embedded in a dense extracellular 
matrix (Figure 6 D,E,F).  In lower vertebrates the mesenchyme of the dorsal fin has 
been classically assumed to be completely neural crest-derived (Du Shane, 1935; 
Raven, 1931), for schematic see (Tucker and Slack, 2004). To confirm the neural 
crest origin of dorsal fin mesenchyme, we replaced trunk neural folds (8 cases) and 
cranial folds in addition to trunk neural folds (2 cases) with GFP+ tissue at stage 16 
and examined whether the dorsal fin was homogeneously labeled (Figure 7A). 
Surprisingly only the apical portions of the dorsal fin epidermis (stage 40-41) were 
GFP+ in all larvae (Figure 7B).  Transverse vibratome sections (4 individuals) 
showed that only half of the internal fin mesenchyme cells were GFP+ and also 
demonstrated the complete and specific labeling of the neural crest (Figure 7C). These 
results suggested a possible additional non-neural crest contribution to the dorsal fin 
mesenchyme.  
 
A hint to a potential additional source of dorsal fin mesenchyme came from PAX7 
immunohistochemistry of stage 39-40 animals.  In addition to the expected 
immunostaining in the dorsal neural tube (but not in the neural crest nor neural crest 
derived structures such as dorsal root ganglia), PAX7+ cells were observed in the 
dermatome (Figure 7D) as well as some cells in the dorsal fin mesenchyme (Figure 
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7D). This raised the possibility that the dermatome may contribute mesenchyme to the 
dorsal fin. To test this, we grafted GFP+ somites into unlabeled hosts at stage 23, well 
before neural crest has delaminated and migrated from the neural tube (Figure 7E). 
Six out of seven larvae (stage 42) displayed GFP+ cells in the dorsal fin that 
sometimes populated even the apical-most regions of the fin (Figure 7F, G). 
Transverse sections revealed that labeled cells were localized within the mesenchyme 
(Figure 7H).  As expected, no GFP+ neural crest derivatives were found in such 
grafted animals, confirming the specificity of the transplant.  These experiments 
indicate that dorsal fin mesenchyme derives not only from neural crest but also 
significantly from the dermatome of the somites. 
 
Figure 7. Dual origin of dorsal fin mesenchyme. A. Schematic showing grafting 
of GFP+ neural folds to unlabelled hosts in order to investigate the contribution 
of neural crest to the dorsal fin. Both cranial and trunk neural folds were 
labeled. B. Left side of a white axolotl larva (head to the left, outside the image; 
stage 40-41) in which both cranial and trunk neural folds had been replaced with 
GFP+ neural folds as depicted in A. The label is visible in the apex of the dorsal 
fin epidermis (epi), the neural tube (nt) and the middle lateral line nerve (m). 
Dotted line denotes the level of transverse section shown in C. C. Transverse 
vibratome section through the larva shown in B demonstrates labeling of the 
apical part of the dorsal fin epidermis (epi). Fin mesenchyme is only sparsely 
labeled.  Higher magnification views showed approximately 50% of 
mesenchymal cells labeled (data not shown).  Dorsal neural tube (nt) and dorsal 
root ganglia (drg) are stained. D. Anti-PAX7 immunostaining of a transverse 
paraffin section through the trunk of a larva at stage 39-40. Cells in the dorsal 
neural tube (nt), dermatome (d) and dorsal fin mesenchyme (arrow) reacted 
positively. E. Grafting of one, left, GFP+ mid-trunk somite to unlabelled host in 
order to investigate possible contribution of dermatome cells to dorsal fin 
mesenchyme. F. Left side of a white axolotl larva (head to the left, outside the 
image; stage 40-41) in which one somite had been replaced with a GFP+ somite 
as described in E. GFP+ cells, very likely dermatome cells, have left the somite 
and havew migrated into the dorsal fin (df; enlargement see G). H. Transverse 
vibratome section through GFP+ somite revealing migrated GFP+ cells (arrows) 
within the dorsal fin mesenchyme. Scale bars: B, 250 µm; C,D,F,H, 100 µm; G, 
50 µm. 
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2.8 The contribution of blood cells to tail regeneration. 
 
In the following experiments, we have used embryonic transplantation of the blood 
anlage in order to label blood in the developing axolotl larvae, in order to track the 
fate of blood cells during tail regeneration. At stage 18, we transplanted posterior 
ventrolateral mesodermal areas (with overlying epidermis) that will form the ventral 
blood islands (Figure 8A) (Yamada, 1938). In urodeles, this region appears to be the 
major source of primitive and definitive hematopoiesis (Deparis and Jaylet, 1984) 
(Durand et al., 2002). Of 30 transplants, 3 animals survived to 2 cm long larval stages 
where we could follow the course of tail regeneration. To estimate the percentage of 
circulating blood that derived from the GFP graft, we acquired blood samples from 
the fully GFP+ germline transgenic animals and compared it to blood from one of the 
grafted animals (Figure 9). In the fully transgenic animals, the erythrocytes were not 
GFP+ while the non-erythrocytic white blood cells were GFP+ resulting in 3.2% of 
the circulating blood cells being GFP+ in the fully transgenic animals. When we 
examined the blood from one of the grafted animals, 1% of the circulating blood was 
GFP+ indicating that we had labeled a significant proportion of the blood-forming 
region. It is important to note here, that axolotl erythrocytes, despite of having a 
nucleus, don’t express GFP, what was confirmed by Western blot analysis. This is 
due to transcriptional repression in these cells (Walmsley et al., 1991). In the grafted 
animals, we could observe GFP+ cells in circulating blood, as well as GFP+ cells that 
were evenly distributed throughout the tail including the dorsal fin (Figure 8B and C). 
The primary cell type that we observed labeled were Langerhans cells, identified 
based on morphology, which are dendritic cells primarily found in skin, dermis and 
lymph nodes. Figure 8D and E show Langerhans cells with their characteristic cell 
extensions. The occurrence of GFP+ cells containing melanin granules inside their 
cytoplasm (Figure 8E) confirms that these are Langerhans cells that are processing 
skin antigens (for review see: (Romani et al., 2003). We also observed other cells with 
a smaller, rounded to polygonal shape, that are presumably macrophages and 
leukocytes (Figure 8F) (Jones and Corwin, 1996). The presence of Langerhans cells 
and macrophages confirms that our transplants label myeloid lineages. 
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Figure 8. Identification of GFP+ blood cell types in the mature tail after grafting 
GFP+ blood anlage to unlabelled hosts. A. Schematic showing grafting of GFP+ 
ventro-lateral tissue at stage 18 to unlabelled hosts and the subsequent pattern of 
labeling observed in the tail. sc – spinal cord, not – notochord. B. Fluorescent 
image of a tail derived from grafting experiments. C. Overlay of fluorescence 
and bright field image. D. High magnification images of a Langerhans cell in the 
dorsal fin; DIC, fluorescence and overlaid images. E. High magnification images 
of a Langerhans cell in the dorsal fin that has taken up melanin granules; DIC, 
fluorescence and overlayed images. F. A second subtype of GFP+ cell that likely 
represents a macrophage; DIC, fluorescence and overlaid images. Scale bars: B, 
C  0.5mm; D, E, F  50µm.  
 
 
Figure 9. Distribution of GFP+ cells in the blood from an animal with 
transplanted blood forming region compared to blood of GFP+ transgenic 
axolotl. Blood was collected from the tail and the heart. A and B show the low 
magnification DIC and fluorescent image, respectively, of the blood of the 
experimental animal. C and D represent the DIC and fluorescent image of the 
distribution of GFP+ cells in the blood from GFP+ transgenic axolotl. 
 
To determine the contribution of blood cells to regenerating tissues we amputated the 
grafted animals when they were 2 cm long larvae and allowed the tail to regenerate 
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for 2 weeks (Figure 10A).  Each animal was amputated twice, bringing the total 
number of observations to six. Tail amputation caused rapid blood efflux, followed 
within several minutes by the formation of a blood clot. After several hours the blood 
clot was enclosed by the wound epidermis and became part of the blastema. One day 
post-amputation we observed an accumulation of GFP+ cells close to the amputation 
plane, either as a result of blood clotting, or due to the migration of GFP+ cells 
towards the wound (Figure 10D). Analysis of the regenerated part of the tail within 
the first few days after the lesion shows that the GFP+ cells that appear in the 
regenerated tissue are similar in shape as those in the tail before the regeneration 
(Figure 11). After 13 days, we observed the same even distribution of stellate GFP+ 
cells in the tail, with no contribution to muscle, cartilage or spinal cord  (Figure 10H, 
I). Transverse sections of the regenerated tail confirmed that the GFP+ cells were not 
located within muscle, cartilage or spinal cord tissue. 
Due to the stability of the GFP marker in transplanted animals, we are able to track 
the fate of those cells over the course of development. In those transplanted animals, 
at the age of three months we observe a number of muscle fibers appearing in the 
non-amputated area of the tail. In all cases, muscle fibers appear in the close 
proximity of the amputation plane. However, it is unclear whether those cells 
originated from hematopoietic cells via transdifferentiation, or blood derived cells 
fused with muscle progenitor cell. Therefore, in this case, a long-term cell tracking 
needs to be preformed supported by histological analysis of the tissues of interest. 
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Figure 10. Tail amputation of transplanted animals containing GFP+ blood cells. 
A. Schematic showing grafting of GFP+ ventro-lateral tissue at stage 18 to 
unlabelled hosts and the subsequent pattern of labeling observed in the tail. 
After reaching a size of 1.5-2 cm animals were subjected to amputation and the 
contribution of GFP+ blood and its derivatives to the regenerated tail was 
followed over 13 days.  sc – spinal cord, not – notochord. B and C Fluorescent 
and overlay images of the tail preamputation. D and E Fluorescent and overlay 
images respectively of the regenerated tail after one day. Arrow indicates group 
of cells embedded in the blood clot.  F and G Regenerated tail after five days 
(fluorescence and overlay respectively). GFP+ cells have populated the growing 
blastema.  H and I Almost fully regenerated tail after 13 days, where tail 
structures including spinal cord, cartilage and muscle have started 
differentiating. GFP+ cells populated the regenerated tail with a similar 
distribution as in the mature tissue.  No labeling of muscle fibers, spinal cord or 
cartilage was observed.  Scale bars: B – I  0.5mm. 
 
 
Figure 11. Representative spectrum of cells observed in the regenerated tail.  
Left, DIC; Middle, Fluorescence; Right, overlay.  Scale bars, 25 µm.  
45 
 
2.9 Can blastema contribute to the spinal cord? 
 
There are two notions of a blastema origin. One, postulates that stem cells residing in 
the tissue and their activation upon injury the main source of blastema structure 
(Cameron, 1986; Weiss, 1939). Second, discusses the phenomenon of 
dedifferentiation of mature cells as a source of blastema. Butler (Butler, 1942) 
formulated the theory of “local origin” of blastema, where dedifferentiation of 
mesodermal tissues at the amputation plane contributes to the blastema. The “model” 
was further observed in work of Hay (Hay, 1959; Hay and Fischman, 1961), where 
histological analysis showed DNA synthesis in muscle nuclei, loss of distinct muscle 
myofibrillar structure and presence of those cell within the blastema structure. 
Another source of blastema cells was shown by Muneoka and colleagues (Muneoka et 
al., 1986). Using diploid/triploid marker system they confirmed that dermis and 
cartilage contribute to the blastema. Moreover, most recent experiment done by 
Echeveri (Echeverri et al., 2001) points toward a dedifferentiation of a mature muscle 
fiber as a main contributor to the blastema.  
If stem cells and dedifferentiation of mature tissues contributes to blastema, are those 
blastema cells equally pluripotent or the structure is a poll of heterogenous cells with 
distinct potentials (Figure 12)? This problem is still an open question in the field and 
only development of more sophisticated tools can help to answer those questions.  
Tail regeneration in axolotl occurs through the phase of blastema formation. 
However, the spinal cord seems to reconstitute itself and already after 2 days the 
distinct shape of the terminal vesicle is visible. The spinal cord grows as a separate 
entity within the blastema environment and itself regenerates all cells withing the 
structure (Benraiss et al., 1999; Egar et al., 1970; Nordlander and Singer, 1978). What 
is incredibly interesting, the urodele amphibians are the only vertebrate that can 
regenerate fully functional spinal cord. In the axolotl, the spinal cord maintains 
neurogenic activity throughout the whole life of the animal constantly providing 
undifferentiated neural stem cells (Holder et al., 1991). There is evidence of 
ependymal cells residing in the lumen of the spinal cord switching their fate to other 
types of cells in the regenerating tail. The change in the identity goes as far as 
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switching germlayer lineage from ectoderm to mesoderm as it is in neural to muscle 
cell type transition (Echeverri and Tanaka, 2002a).  
 
 
Figure 12. Possible models of blastema cells characteristic. Blastema becomes a 
pool of multipotent cells with no specific restriction in fate. Second, blastema is a 
mixture of pluripotent cells and restricted in fate progenitor cells. Third, 
blastema cells remain restricted to their lineage. 
 
The evidences available so far regarding blastema cells origin allow the prediction, 
that cells at the amputation plane turn on a cascade of signals driving the mature cells 
to dedifferentiate (confirmed by the loss of tissue identity markers, e.g. muscle 
markers) and take up the characteristics of progenitor cells. The pluripotency of these 
cells is still to be determined. However, the notion directs models towards stem-cell-
like dedifferentiation or at least to a high level of pluripotency. Having both in mind, 
the obvious questions arise: are blastema cells pluripotent? Can the structure of the 
spinal cord be reconstituted form blastema cells? 
In order to address these questions, the experiment was designed where a GFP+, 4 
day blastema was transplanted into the place of a removed fragment of the spinal cord 
(Figure 13A). There was a possibility of the presence of neural progenitors in the 
blastema. To exclude this, every implanted blastema was divided in half, where one 
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half of the blastema was implanted into the tail and the second half was sectioned and 
stained against a glial marker GFAP (Figure 14).  
Animals subjected to transplantation (Table 6) were allowed to recover, and after 3, 5 
and 8 days the tail was amputated and the part with the transplant was fixed, sectioned 
and stained against GFAP to examine if GFP+ cells contributed to the structure of the 
regenerating spinal cord. (Figure 15) 
 
 
Nr of 
transplanted 
animals 
Nr of animals 
sectioned after 
3 days 
Nr of animals 
sectioned after 
5 days 
Nr of animals 
sectioned after 
8 days 
Nr of animals 
allowed to 
complete 
regeneration 
36 9 9 11 7 
Table 6. 36 animals were subjected to transplantation of GFP+ blastema into the 
injured spinal cord. Animals were divided in groups and tails were sectioned at 
different time points of regeneration. 7 animals were allowed to complete 
regeneration. 
 
Animals that were allowed to fully regenerate contained GFP+ muscle cells and 
cartilage (Figure 13B-E). No contribution of blastema to the spinal cord was 
observed. In most cases, groups of blastema cells were pushed away from the 
regenerating spinal cord part and located either between the spinal cord and cartilage 
or on the side of the spinal cord.  
To observe the possible contribution of blastema cells to regenerating spinal cord in 
time, animals were sectioned in three stages of regeneration – 3, 5 and 8 days. Each 
specimen was sectioned and stained against GFAP. In all cases no single cell positive 
for both GFP and GFAP was detected. Only several, morphologically definable GFP+ 
cartilage cells were found (Figure 15 – example at 5 days). 
It still remains to be clarified how transplanted cells would populate the regenerating 
tail if animals were left to grow for a longer period of time (e.g. 2 months after 
transplantation) or what the fate of those cells would be when they would have been 
subjected to amputation. The question here is whether the regeneration completes its 
programme within the first two weeks after injury or if we could call regeneration not 
only reconstitution of the lost appendage, but also rebuilding of the whole structure 
including the patterning of muscle segmentation. 
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Figure 13. Schematic diagram showing 3 cm long GFP+ axolotl amputated tails, 
which were allowed to regenerate to the 4-day blastema. (A) Blastema was 
dissected and divided in two fragments. One fragment was fixed, sectioned and 
stained with antibody against GFAP (Figure 14). The second fragment was 
implanted into the injured spinal cord of a white mutant 3 cm long axolotl in the 
middle of the tail. B and E show the regeneration of the representative tail. No 
contribution of GFP+ cells to the spinal cord was observed. Scale bars: 0.5mm. 
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Figure 14. GFP+ blastema was sectioned and stained with antibody against 
GFAP in order to exclude the possibility of the presence of neural progenitor 
cells. Panels A-D and E-H show two representative blastemas where no GFAP+ 
cells were detected. Scale bar: 100 µm. 
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Figure 15. Regions where GFP+ blastema cells were transplanted into the spinal 
cord were fixed and sectioned at different time points. Sections were stained with 
antibody against GFAP (M-P). Vertical panels represent four different tails: A, 
E, I, M – represent the tail sectioned three days after implantation. Spinal cord 
stained with GFAP (red) is surrounded with GFP+ cells from the transplant. B, 
F, J, N - represent the tail sectioned five days after implantation. Green cells 
exited the spinal cord region and are visible in the area of dedifferentiating 
muscle. C, G, K, O - represent another example of the tail sectioned five days 
after implantation. Green cells contributed to the regenerating cartilage. D, H, L, 
P - represent the tail sectioned eight days after implantation. No GFP+/GFAP+ 
cells were detected. GFP+ cells are visible in the area of muscle. All sections were 
stained with DAPI to visualize nuclei (E-H).  
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2.10 Future of transgenesis in the axolotl 
 
We have shown so far that using fairly simple methods it is possible to obtain 
transgenesis in the axolotl. The great advantage of the GFP+ axolotl over tools 
available previously, is its stable expression of the GFP protein that can be followed 
continuously through the whole life of the animal and during regeneration in vivo. 
One advantage of the axolotl system in regeneration research is the possibility to 
study regeneration on the same animal several times, while collecting the regenerated 
part for histological analysis and observe the regeneration in the same conditions 
again.  
Experiments described in this dissertation showed that transgenesis in the axolotl is 
feasible. However, the ultimate transgenesis goal in the axolotl is the implementation 
of a Cre-loxP system (Nagy, 2000) in order to label tissues and cells specifically and 
follow the fate of a single cell in the regeneration process. Cre recombinase efficiently 
catalyzes recombination between two of its recognition sites (loxP sites) flanking the 
gene in any environment and in any cell. The sophisticated nature of this system is 
shown on Figure 16.  
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Figure 16. Schematic diagram of Cre-loxP system for implementation in the 
axolotl system. 
 
Implementation of this system allows conditional manipulation of reporter gene 
expression and would open numerous possibilities for cell fate tracing and gene 
expression analysis.  
A very interesting problem in regeneration is the origin of blastema cells and their 
ultimate fate. A great example of the application of the Cre-loxP system in 
regeneration studies is to reveal the fate of the muscle fiber. Does muscle fiber dies or 
does it dedifferentiate to populate blastema with progenitor cells? Are those muscle-
derived blastema cells restricted in their fate to form muscle again, or upon 
dedifferentiation do they acquire potency to transdifferentiate? The possible outcomes 
of muscle cell fate tracing experiment are shown on Figure 17.  
 
 
Figure 17. Possible application of Cre-loxP system in transgenesis in the axolotl. 
Construct pHcRDR is ubiquitously expressed in every tissue of the tail. Upon 
Cre-mediated recombination in muscle cells, this tissue is clearly distinguishable 
from the rest of the body. Upon amputation, a blastema is formed, and very 
likely will contain a mixture of red and green cells. After the complete 
regeneration we will be able to define what is the fate of muscle fibers in the 
regenerating tail. 
 
Preliminary experiments to test this system in the axolotl were performed. The 
construct used for this analysis, pHcRDR, is a double reporter gene, where the 
CAGGs promoter drives the expression of HcRed (flanked by loxP sites) followed by 
an inactive GFP sequence. Upon Cre mediated recombination, the HcRed sequence is 
removed from the transgene, allowing the promoter to drive the expression of GFP 
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and resulting in the change of colour in the visible marker in the cell(s) where the 
recombination took place.  
In the axolotl, this would allow induction of the expression of GFP only in single 
cells, whose fate could be further followed during the regeneration of the tail.  
To test whether the Cre-loxP system works in the axolotl, we bulk-electroporated a 
mixture of pHcRDR and MCK-Cre plasmid into the axolotl tail. Animals were 
allowed to heal and after 3 days expression was analyzed (Figure 18).  
 
 
Figure 18. The axolotl tail was electroporated with plasmids pHcRDR and 
MCK-Cre. After 3 days the transient expression of HcRed was observed in 
muscle fibers and spinal cord along the tail (D) but GFP expression was only 
observed in muscles (B) as a result of recombination induced by Cre 
recombinase. A. DIC image of the electroporation region. C. overlay of DIC, 
green and red fluorescence. Scale bar - 200µm 
 
We were able to show that Cre recombinase effectively excised the HcRed gene from 
the plasmid and induced expression of the GFP gene. Although the ability to 
implement this system in the axolotl is without question, we cannot use 
electroporation of the pHcRDR plasmid. The expression here was transient and 
amputation of such tails resulted in the quick loss of the marker and again we were 
not able to follow the fate of the cells. The only way to answer this question is to 
produce transgenic a animal ubiquitously expressing a double reporter plasmid, such 
as pHcRDR, and deliver Cre recombinase to a specific tissue at later stages. In this 
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way, the expression of the pHcRDR will be stable, will not be lost upon 
dedifferentiation and will not change or disappear upon the change in a cells identity. 
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3  DISCUSSION 
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The ability to produce transgenic axolotls with relative ease opens up numerous 
opportunities for producing animals harboring other cell markers, and for 
manipulating gene expression in the axolotl, an important dimension that was 
previously unavailable for this animal. As shown here, an important aspect is the 
differing temporal expression profiles of supposedly constitutive promoters, where 
expression from some promoters was lost over time.  Further studies will be needed to 
determine whether a broad scope of promoters will be functional in these transgenics.  
In Xenopus, faithful tissue specific expression has been observed using promoters 
from heterologous species (Hartley et al., 2001). We expect that such promoters 
would display the same tissue specificity using the plasmid injection technique. 
While a broader assessment of the transgenic technique regarding different promoters 
and transgenes is necessary work for the future, an emphasis of the work described 
here is the use of the GFP germline transgenic animal for cell tracking experiments 
during development and regeneration.  These GFP+ animals are an important tool for 
embryological and regeneration experiments where specific cell or tissue types need 
to be followed over long periods of time. Previously, grafting experiments in axolotls 
were performed using either triploid nucleoli or skin pigment which both have major 
limitations for analysis (Muneoka et al., 1984; Pescitelli and Stocum, 1980). The 
pigmentation grafts are only useful in grafts containing skin. In the triploid nucleoli 
technique, only a proportion of the grafted cells contained three nucleoli and are 
distinguishable from host cells (Muneoka et al., 1984). Thus, there is not a one-to-one 
correspondence of grafted cells to the marker. Secondly, the grafts can only be 
analyzed upon fixation and histological analysis.  In contrast, GFP+ tissue can be 
followed dynamically over time in live animals, and provides an indelible marker 
with high spatial resolution, as shown here in our studies of the dorsal fin, and of 
blood during regeneration. 
Classical transplantation experiments demonstrated that neural crest cells contribute 
to the dorsal fin mesenchyme (Raven, 1931; Raven, 1936) and since that time it has 
been assumed that neural crest is the sole contributor of mesenchymal cells of the 
dorsal fin (see (Bodenstein, 1952; Tucker and Slack, 2004) Our experiments where 
we transplant complete GFP+ neural folds indicated that only approximately 50% of 
the dorsal fin mesenchyme came from neural crest.  Transplantation of GFP+ somites 
at stage 23 resulted in GFP+ dorsal fin mesenchyme, indicating that somites 
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(presumably dermatome) also contribute cells to the dorsal fin mesenchyme. In light 
of our new findings, it is possible to re-interpret Bodenstein’s (Bodenstein, 1952) 
transplantation results as being consistent with a dual, neural crest and somite origin 
of dorsal fin mesenchyme.  Bodenstein transplanted prospective dorsal fin epidermis 
laterally over somites at stage 28 and observed the formation of a proper dorsal fin 
containing mesenchymal cells.  He interpreted this result as indicating that the neural 
crest cells that had migrated out of the neural tube and populated the somites, had 
contributed to the ectopic dorsal fin mesenchyme.  Our somite transplantations were 
performed well before neural crest delamination and migration which start in the 
anterior trunk at stages 27 and 31, respectively, (Epperlein and Lofberg, 1990), 
eliminating the possibility that the somite-derived fin mesenchyme derives from 
migrating neural crest.  In a second set of experiments, Bodenstein transplanted dorsal 
tissue that included ectoderm and the dorsal half of the neural tube to the ventral 
midline in order to observe if these two cell layers were sufficient to form dorsal fin at 
an ectopic site. The ectopic fins that formed were approximately half the size of the 
normal fin.  When the same dorsal tissue pieces were transplanted over somites, full 
sized fins formed. In a third set of experiments, when dorsal tissue that included 
ectoderm, neural tube and somites was transplanted into the ventral midline, full-sized 
fin structures formed. Thus, there was a strong association of full-sized fin formation 
with the presence of somites.  Our experiments here indicate that this is due to a major 
contribution of somites to dorsal fin mesenchyme. 
An important question for the future is whether the contribution of somites to fin 
mesenchyme is a feature specific to urodele amphibians or whether it is generally 
found in all lower vertebrates with fins. Smith and colleagues (Smith, 1994) used DiI 
labeling to characterize the source of fin mesenchyme in zebrafish.  Labeling of 
neural crest resulted in labeled cells in the dorsal fin mesenchyme, while labeling of 
somites did not.  At this point, it is unclear whether this difference to our results is due 
to a difference in fin formation between species, or to a technical difference in the 
experiments. 
Here we have also used embryonic transplantation of GFP+ blood anlage to test the 
frequency and role of hematopoietic cell plasticity during tail regeneration. By 
transplanting the embryonic blood-forming region, it is possible to label blood cells, 
including the stem cells that give rise to hematopoietic cells.  The axolotl may be an 
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ideal model system for such experiments, since it is thought that the blood (primitive 
and definitive) derives solely or largely from the ventral blood islands rather than 
from additional dispersed sites (Durand et al., 2002). Since the tail is distant from the 
blood-forming region in the main body, a large graft of the ventral body tissue does 
not interfere with the specificity of visualizing blood in the tail.   
So far we have observed no contribution of labeled blood cells to muscle or central 
nervous system, as was reported in the mouse (Brazelton et al., 2000; Ferrari G., 
1998; Mezey et al., 2000). It is difficult to compare quantitatively the frequency of 
cell type switching occurring in the mouse with our results.  During the course of our 
experiments we estimate that we have tracked in total approximately 600 GFP+ 
blood-derived cells (non-circulating), but the total number of stem cells, for example, 
that we are tracking is unknown.  Comparison of GFP+ cells in circulating blood in 
the germline transgenic animals versus a grafted animal indicated that we had labeled 
up to 30% of the total blood cell population.  
Our results, indicating that blood cells do not contribute significantly to regenerating 
tissues are consistent with classical irradiation experiments performed to determine 
whether the regenerating limb blastema arises locally from cells at the amputation 
plane, or from distant cells (such as circulating blood cells) that would home to the 
injury site (Butler, 1942). In these experiments, a segment of the left hindlimb was 
exposed to X-irradiation while the rest of the body was shielded. When the limb was 
amputated in the exposed region regeneration did not occur, while amputation 
through the shielded regions did result in regeneration. These experiments indicated 
that the main proportion of cells involved in limb regeneration arise from the tissue at 
the amputation plane. Our results coupled with the Butler and O’Brien work indicate 
that although hematopoietic cells may have the potential to form distant cell types, 
this plasticity is not utilized or required for regeneration of complex structures such as 
the limb or tail. Our results would thus imply that a more important issue for 
understanding regeneration is how tissues at the injury site such as muscle, dermis 
and nerve are induced to produce the progenitor cells of the blastema.  
In the transplantation of blastema cells into the spinal cord we attempted to determine 
whether blastema cells show the level of plutipotency allowing them to reconstitute 
every cell type in the tail. So far, it is still not clear whether stem cells residing in the 
tissue populate blastema upon injury mediated activation and what is the extent of 
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their contribution to the blastema. We were not able to detect neural progenitor cells 
in the blastema or blastema cells contribution to the spinal cord, suggesting that 
neural tissue within regenerating tail mainly reconstitutes itself from the spinal cord 
structure.  
To answer very important for a regeneration research in the axolotl questions of origin 
of the blastema and fate of mature tissues during regeneration it is of great importance 
to pursue the development of transgenesis towards implementation of inducible 
expression systems, such as Cre-loxP system. It would allow manipulations with 
marker gene expression in desired place in the animal and studying its effect in 
desired time, e.g. during development or regeneration.  
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4  MATERIALS AND METHODS 
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4.1 Animal care, embryo handling and injection protocol 
 
All axolotls were bred and raised in the laboratory.  In all experiments, white mutant 
(d/d) axolotls were used.  Axolotls were staged according to the normal tables from 
(Bordzilovskaya, 1989). In all injection experiments embryos were used at the one 
cell stage.  Embryos were collected in the morning and kept in tap water at 4°C until 
the time of injection to assure they remained at the one cell stage. All embryos were 
dejellied manually with fine forceps (Dumont 5, Fine Science Tools, Germany) and 
kept in 1xMMR with penicillin-streptomycin (Invitrogen GmbH, Germany). Our 
experience in embryo handling allows us to say that careful manual dejellying does 
not harm embryos and has very little effect on survival. However, since different 
spawns of embryos had differing survival rates, one part of each spawn was left as a 
quality and viability control. Control, non-dejellied, embryos were kept in aerated 
water.  
Prior to injection embryos were transferred to chilled 20% Ficoll/1xMMR/pen-strep. 
(Ficoll obtained from Sigma, Germany).  Injections were performed at the one-cell 
stage (at 22°C the time from fertilization to the first division is 6 hours; 
(Bordzilovskaya, 1989). Injections were performed using a pressure injector 
Picospritzer II (Parker Instrumentation) mounted alongside of an Olympus Stereo 
SZX12 dissecting microscope. Glass capillary needles were prepared on a 
Flaming/Brown micropipette puller; model P-97, (Sutter Instruments Co., USA). 
Needles were back-filled with DNA alone or DNA+ISceI Enzyme (DNA: 0.1µg/µl or 
0.01µg/µl; ISceI enzyme: 1U/µl; 1x meganuclease buffer. Enzyme and buffer were 
obtained from New England Biolabs, USA). 10nl of solution was injected into the one 
cell stage embryo. The optimal injection volume of 10 nl was established by a series 
of plasmid injections in the range of volumes from 30nl to 5nl. A volume of 20nl can 
be used, however it may result in a lower survival rate of embryos depending on their 
quality. After injection embryos were kept in 20% Ficoll/1xMMR solution for 2-3 
hours to prevent yolk leakage and then were transferred to 5% Ficoll/0.1xMMR/pen-
strep and left in this solution overnight. Finally, embryos were transferred to 
0.1xMMR/pen-strep, until the hatching stage, when animals were kept in aerated tap 
water at room temperature. All solutions used for injections and embryo rearing were 
0.22µm filtered. 
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4.2 Grafting GFP+ neural folds and somites 
 
Before being used for grafting white mutant (d/d) GFP+ donor embryos and white  
hosts were washed thoroughly with tap water and sterile Steinberg solution 
(Steinberg, 1975) containing antibiotics. They were then decapsulated manually. For 
grafting GFP+ trunk neural fold material or somites, GFP+ donors and hosts were 
placed into the depression of an agar dish filled with cold Steinberg saline. Grafting 
was performed under sterile conditions using tungsten needles. 
 
4.2.1 A. Neural folds 
Neural folds containing cranial and trunk regions (n=2), or one complete left trunk 
neural fold (n=8) were grafted orthotopically from white GFP+ transgenic neurulae 
(stages 15-17)  into white mutant hosts from which neural fold material of equivalent 
size had been extirpated. Two to four days after the operation the distribution of 
GFP+ cells in the hosts was followed under fluorescence optics. 
 
4.2.2 B. Somites 
For grafting single somites, the epidermis was lifted from the left dorsolateral 
midtrunk of white GFP+ transgenic embryos (stage 23/24). One somite was 
extirpated and implanted into a similar site of a white host where a somite had been 
removed. The epidermis was then folded back over the implanted somite and pressed 
against it with a small glass disc for a few minutes. Migration of GFP+ cells into the 
dorsal fin was followed under fluorescence optics. 
 
4.3 Grafting GFP+blastema into spinal cord. 
 
Tails of 3cm, GFP+ axolotls (n=37) were amputated and allowed to regenerate for 4 
days. Blastema was dissected and divided in two parts. One part was fixed, sectioned 
and stained with GFAP (company) antibody.  The skin of white mutant animals 
(n=37) was peeled off and spinal cord was injured by removing a small fragment of 
spinal cord from the middle of the tail (Fig.13). Second part of the dissected GFP+ 
blastema was implanted in a place of injury and the wound was covered with the skin. 
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Animals were allowed to recover in aerated water with antibiotics (Pen-strep , Sigma, 
Germany) at room temperature. During surgerical procedures animals were 
anesthetized with 0.001% ethyl-p-aminobenzoate (Sigma, Germany). Tails of 
transplanted animals were collected after 3, 5, 8, 17 days and fixed, sectioned and 
stained against GFAP. 
 
4.4 In Vivo Electroporation of axolotl tails. 
 
The electroporation procedure was performed according to Echeverri and Tanaka 
(Echeverri and Tanaka, 2003). Animals were anesthetized with 0.001% ethyl-p-
aminobenzoate (Sigma, Germany) and placed on a platform. The skin was removed, 
to allow the microinjection of the plasmid mix. Plasmids were use in the 
concentration 0.1ug/ul and several nanoliters were injected (using World Precision 
Instrument pressure injector) into the tissue. In the case of this experiment it was 
desired to express the pHcRDR construct in as different population of cells as 
possible, therefore plasmid mix was injected into muscles, cartilage and spinal cord. 
Using SD9 Stimulator (Grass Telefactor) the tail was electroporated with 5 pulses, 
200Hz with the 20msec pulse length. The electroporated tail was covered back with 
the skin, and animals were allowed to recover in 0.1xMMR with antibiotics. 
 
4.5 Histology and immunofluorescence. 
 
Several days after grafting GFP+ tissues larvae were anaesthetized with MS 222 
(Serva) and fixed with 4% paraformaldehyde (PFA) in 0.1 M PBS overnight. Fixed 
specimens were washed and transverse vibratome sections (100 µm) were cut on a 
vibratome series 1000 sectioning system (Ted Pella, Inc.) in order to investigate the 
internal distribution of GFP+ cells. Some PFA-fixed larvae of similar age as larvae 
with GFP+ somites (stage 38) were embedded in paraffin (Leica ASP 300) for 
investigating the distribution of PAX7 positive dermatome cells on transverse 
sections (5 µm). Microwaved transverse sections (5 µm) were stained with a primary 
PAX7 antibody (DSHB) and with biotinylated secondary antibodies and tertiary 
streptavidin-peroxidase complexes (Vectastain ABC-Elite-Kit).  
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In the samples for characterizing the fully GFP transgenic animal, 5 day blastemas of 
GFP+ juveniles, were fixed in 4% PFA overnight at 4°C, washed 3x15min with PBS 
at room temperature and placed in 30% sucrose in PBS overnight at 4°C. Samples 
were mounted in Tissue Tek (Sakura) and cryosections (10 µm) were collected on 
Histobond Adhesion microslides (Marienfeld, Germany). To visualize the structure of 
the tissues, sections were stained with a hematoxylin solution (Sigma, Germany) for 
20 seconds and washed extensively with tap water, followed by a 3-minute wash in 
PBS. Nuclei were stained for 8 minutes with Hoechst followed by 3x5min washes in 
PBS. Slides were mounted using Mowiol and allowed to dry over night.  
In the experiment of transplantation of 4 day GFP+ blastema into the spinal cord, both 
dissected blastemas and tails with implanted blastemas were fixed and sectioned as 
described above. To visualize GFAP+ cells samples were washed several times with 
1xPBS/0.3%Tween, blocked with 10%FBS/1xPBS form 10 min and 
10%FBS/1xPBS/0.3%Tween for 20 minutes, washed once with PBS, placed in GFAP 
antibody solution for 1 hour in 37°C, washed 3x5 minutes in 1xPBS/0.3%Tween, 
covered with secondary antibody TRITC for 1 hour at 37°C, followed by washing 
steps – 3x10minutes in 1xPBS/0.3%Tween. Nuclei were visualized 1ug/ml Hoechst 
solution for 10 min, followed by additional washing 2x5min in PBS, and 1x5min in 
water. Slides were mounted in Mowiol. 
 
4.6 Microscopy 
 
For transgene expression analysis animals were anesthetized with 0.001% ethyl-p-
aminobenzoate (Sigma, Germany), placed on a coverslip and imaged using a 10x 
Plan-Neofluor objective on a Zeiss Axiovert 2 microscope with a CCD camera 
(Diagnostic Instruments, USA) controlled by a Metamorph image acquisition system 
(Visitron). For imaging of dissected GFP+ organs and tissues we used an Olympus 
Stereo SZX12 microscope with fluorescence attachment controlled by Diagnostic 
Instruments software (USA). Sections of GFP+ tissues from transgenic GFP animals 
were imaged on an Olympus BX61 microscope using brightfield and fluorescence 
optics. 
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4.7 Plasmid constructs 
 
Plasmid constructs used in experiments were: pCSKA-hGFP-SceI (5.0kb) (kindly 
provided by C. Grabher) that contains the Xenopus borealis cytoskeleton actin 
promoter driving hGFP flanked by SceI sites. CMVGFP3-ITR (5.3kb). 
pCS2nβgalITR was digested with HindIII and Xho1 to remove the lacZ sequence, 
which was replaced by the GFP3 sequence obtained after HindIII/XhoI digestion of 
XCarGFP3ITR. GFP3 is a version of GFP that was mutated for better expression in 
Xenopus (both plasmids used for this cloning - kind gift of Sylvia Evans). 
pCAGGsEGFP(Sce) (5.9kb) was constructed by insertion of two oligonucleotides 
containing ISceI recognition sequences in opposite orientations flanking the 
pCAGGsEGFP cassette that contains EGFP driven by chicken β-actin promoter with 
CMV-IE ( CAGGsEGFP plasmid kindly provided by F. Stewart). 
Plasmid pHcRDR was a kind gift of Dr. Frank Eddenhoffer, MCK3.3-Cre plasmid 
was kindly provided by Rico Barsacchi.  
Plasmids were purified using MaxiPrep Kits (Quiagen, Germany) (pCSKA-hGFP-
SceI, pCAGGsEGFP(SceF), MCK3.3-Cre and CMVGFP3-ITR), EndoFree Quiagen 
Kit (pCAGGsEGFP and pCAGGsEGFP(Sce)) and cesium chloride preparation 
(pCAGGsEGFP(Sce), pHcRDR). The type of plasmid purification in meganuclease 
injections did not seem to have a significant influence on expression or survival. 
The ISceI meganuclease enzyme (NEB, Germany) was aliquoted and stored at –80°C 
and used according to the teleost protocol available by personal communication with 
Jochen Wittbrodt and Clemens Grabher (Jochen.Wittbrodt@EMBL.de or 
Clemens.Grabher@EMBL.de). 
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5 INDEX OF FIGURES 
 
Figure 1. Four batches of embryos were collected, scored and allowed to develop. 
Three of them have similar rates of survival after 1 month. Occasionally, a very poor 
quality batch occurs. On average, the survival rate of embryos is 60%..................... 20 
Figure 2. Batches of embryos can have a very different quality. Here the effect of 
mechanical damage on healthy and unhealthy embryos during manual dejelling is 
shown. If spawning results in healthy embryos, careful manual dejelling has no effect 
on survival and development of embryos (batch1). However, the mechanical removal 
of the jelly coat from embryos more delicate, or less healthy, caused dramatic 
decrease in survival and severe developmental malformations................................. 21 
Figure 3. Axolotl injected with CAGGsEGFP construct - founder animal of our first 
transgenic line of axolotl. CAGGs - chicken B-actin+IE CMV promoter. A. 
Expression of EGFP after 1 month. The animal is about 1.2 cm long. B. Expression of 
EGFP in the same animal after 6 months. The animal is about 13 cm long. Expression 
at this level was observed until the first mating. C. F1 animals derived from mating 
the GFP+ of transgenic axolotl.  Progeny are at the 2cm long larval stage. GFP is 
ubiquitously expressed all over the body. ................................................................ 25 
Figure 4. Animals obtained from co-injections of GFP plasmid and ISceI 
meganuclease enzyme were scored according to categories A, very strong;  B, strong; 
C, moderate; D, weak. Scale bars: A, D 0.1cm, B 0.5cm, C 0.3cm........................... 30 
Figure 5. GFP fluorescence of major organs and stuctures in GFP-transgenic 
compared to a non-transgenic animal. A and B shows comparison of eyes, C,D 
forelimbs, E,F heart,  G,H liver, I, J lung. On figures A, C, E, G, I brightfield and on 
B, D, F, H, J fluorescent images are shown. Scale bars - A, B, C, D, E, F, I, J - 1mm, 
G, H - 2mm. ............................................................................................................ 34 
Figure 6. High resolution images of GFP fluorescence in cryosections of a 
regenerating axolotl tail.  A regenerating tail of a transgenic fluorescent animal was 
sectioned longitudinally and stained with hematoxylin to visualize cells and Höchst to 
visualize nuclei. A, B, C An overview of the tail tissues. sc – spinal cord, n – 
notochord, b – blastema, e – epidermis. D, E, F  Higher magnification view of tail fin 
cells.  Note in hematoxylin and Höchst staning that cells are widely separated from 
each other via ECM.  All cells are GFP+ . G,H,I, High magnification view of tail 
blastema cells.  All Höchst positive cells are GFP+. A,D,G, hematoxylin staining.  
B,E,H,  GFP fluorescence from transgenic animal, C,F,I overlay of GFP and Hoechst 
staining. Scale bars: A-C 200µm; D-F 100µm; G-I 50µm........................................ 35 
Figure 7. Dual origin of dorsal fin mesenchyme. A. Schematic showing grafting of 
GFP+ neural folds to unlabelled hosts in order to investigate the contribution of 
neural crest to the dorsal fin. Both cranial and trunk neural folds were labeled. B. Left 
side of a white axolotl larva (head to the left, outside the image; stage 40-41) in which 
both cranial and trunk neural folds had been replaced with GFP+ neural folds as 
depicted in A. The label is visible in the apex of the dorsal fin epidermis (epi), the 
neural tube (nt) and the middle lateral line nerve (m). Dotted line denotes the level of 
transverse section shown in C. C. Transverse vibratome section through the larva 
shown in B demonstrates labeling of the apical part of the dorsal fin epidermis (epi). 
Fin mesenchyme is only sparsely labeled.  Higher magnification views showed 
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approximately 50% of mesenchymal cells labeled (data not shown).  Dorsal neural 
tube (nt) and dorsal root ganglia (drg) are stained. D. Anti-PAX7 immunostaining of a 
transverse paraffin section through the trunk of a larva at stage 39-40. Cells in the 
dorsal neural tube (nt), dermatome (d) and dorsal fin mesenchyme (arrow) reacted 
positively. E. Grafting of one, left, GFP+ mid-trunk somite to unlabelled host in order 
to investigate possible contribution of dermatome cells to dorsal fin mesenchyme. F. 
Left side of a white axolotl larva (head to the left, outside the image; stage 40-41) in 
which one somite had been replaced with a GFP+ somite as described in E. GFP+ 
cells, very likely dermatome cells, have left the somite and havew migrated into the 
dorsal fin (df; enlargement see G). H. Transverse vibratome section through GFP+ 
somite revealing migrated GFP+ cells (arrows) within the dorsal fin mesenchyme. 
Scale bars: B, 250 µm; C,D,F,H, 100 µm; G, 50 µm................................................ 37 
Figure 8. Identification of GFP+ blood cell types in the mature tail after grafting 
GFP+ blood anlage to unlabelled hosts. A. Schematic showing grafting of GFP+ 
ventro-lateral tissue at stage 18 to unlabelled hosts and the subsequent pattern of 
labeling observed in the tail. sc – spinal cord, not – notochord. B. Fluorescent image 
of a tail derived from grafting experiments. C. Overlay of fluorescence and bright 
field image. D. High magnification images of a Langerhans cell in the dorsal fin; DIC, 
fluorescence and overlaid images. E. High magnification images of a Langerhans cell 
in the dorsal fin that has taken up melanin granules; DIC, fluorescence and overlayed 
images. F. A second subtype of GFP+ cell that likely represents a macrophage; DIC, 
fluorescence and overlaid images. Scale bars: B, C  0.5mm; D, E, F  50µm............. 41 
Figure 9. Distribution of GFP+ cells in the blood from an animal with transplanted 
blood forming region compared to blood of GFP+ transgenic axolotl. Blood was 
collected from the tail and the heart. A and B show the low magnification DIC and 
fluorescent image, respectively, of the blood of the experimental animal. C and D 
represent the DIC and fluorescent image of the distribution of GFP+ cells in the blood 
from GFP+ transgenic axolotl.................................................................................. 41 
Figure 10. Tail amputation of transplanted animals containing GFP+ blood cells. A. 
Schematic showing grafting of GFP+ ventro-lateral tissue at stage 18 to unlabelled 
hosts and the subsequent pattern of labeling observed in the tail. After reaching a size 
of 1.5-2 cm animals were subjected to amputation and the contribution of GFP+ blood 
and its derivatives to the regenerated tail was followed over 13 days.  sc – spinal cord, 
not – notochord. B and C Fluorescent and overlay images of the tail preamputation. D 
and E Fluorescent and overlay images respectively of the regenerated tail after one 
day. Arrow indicates group of cells embedded in the blood clot.  F and G Regenerated 
tail after five days (fluorescence and overlay respectively). GFP+ cells have populated 
the growing blastema.  H and I Almost fully regenerated tail after 13 days, where tail 
structures including spinal cord, cartilage and muscle have started differentiating. 
GFP+ cells populated the regenerated tail with a similar distribution as in the mature 
tissue.  No labeling of muscle fibers, spinal cord or cartilage was observed.  Scale 
bars: B – I  0.5mm................................................................................................... 44 
Figure 11. Representative spectrum of cells observed in the regenerated tail.  Left, 
DIC; Middle, Fluorescence; Right, overlay.  Scale bars, 25 µm. .............................. 44 
Figure 12. Possible models of blastema cells characteristic. Blastema becomes a pool 
of multipotent cells with no specific restriction in fate. Second, blastema is a mixture 
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of pluripotent cells and restricted in fate progenitor cells. Third, blastema cells remain 
restricted to their lineage. ........................................................................................ 46 
Figure 13. Schematic diagram showing 3 cm long GFP+ axolotl amputated tails, 
which were allowed to regenerate to the 4-day blastema. (A) Blastema was dissected 
and divided in two fragments. One fragment was fixed, sectioned and stained with 
antibody against GFAP (Figure 14). The second fragment was implanted into the 
injured spinal cord of a white mutant 3 cm long axolotl in the middle of the tail. B and 
E show the regeneration of the representative tail. No contribution of GFP+ cells to 
the spinal cord was observed. Scale bars: 0.5mm..................................................... 48 
Figure 14. GFP+ blastema was sectioned and stained with antibody against GFAP in 
order to exclude the possibility of the presence of neural progenitor cells. Panels A-D 
and E-H show two representative blastemas where no GFAP+ cells were detected. 
Scale bar: 100 µm. .................................................................................................. 49 
Figure 15. Regions where GFP+ blastema cells were transplanted into the spinal cord 
were fixed and sectioned at different time points. Sections were stained with antibody 
against GFAP (M-P). Vertical panels represent four different tails: A, E, I, M – 
represent the tail sectioned three days after implantation. Spinal cord stained with 
GFAP (red) is surrounded with GFP+ cells from the transplant. B, F, J, N - represent 
the tail sectioned five days after implantation. Green cells exited the spinal cord 
region and are visible in the area of dedifferentiating muscle. C, G, K, O - represent 
another example of the tail sectioned five days after implantation. Green cells 
contributed to the regenerating cartilage. D, H, L, P - represent the tail sectioned eight 
days after implantation. No GFP+/GFAP+ cells were detected. GFP+ cells are visible 
in the area of muscle. All sections were stained with DAPI to visualize nuclei (E-H).
................................................................................................................................ 50 
Figure 16. Schematic diagram of Cre-loxP system for implementation in the axolotl 
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Figure 17. Possible application of Cre-loxP system in transgenesis in the axolotl. 
Construct pHcRDR is ubiquitously expressed in every tissue of the tail. Upon Cre-
mediated recombination in muscle cells, this tissue is clearly distinguishable from the 
rest of the body. Upon amputation, a blastema is formed, and very likely will contain 
a mixture of red and green cells. After the complete regeneration we will be able to 
define what is the fate of muscle fibers in the regenerating tail. ............................... 52 
Figure 18. The axolotl tail was electroporated with plasmids pHcRDR and MCK-Cre. 
After 3 days the transient expression of HcRed was observed in muscle fibers and 
spinal cord along the tail (D) but GFP expression was only observed in muscles (B) as 
a result of recombination induced by Cre recombinase. A. DIC image of the 
electroporation region. C. overlay of DIC, green and red fluorescence. Scale bar - 
200µm..................................................................................................................... 53 
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7 ABBREVIATIONS 
 
 
AAV ITR  Adeno-associated Viral Inverted Terminal Repeats 
CAGGs promoter: chicken beta actin + CMV IE enhancer 
CMV Cytomegalovirus 
CSKA cytoskeletal actin 
F0,F1 generation of transgenic animals – F0 being the founder, F1 – 
first generation of progeny 
GFAP Glial Fibrillary Acidic Protein 
GFP Green Fluorescent Protein 
MCK Muscle Creatine Kinase  
MMR Mark’s Modified Ringers 
PFA paraformaldehyd 
PBS Phosphate Buffered Saline 
REMI     Restriction Enzyme – Mediated Integration 
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